LINK LINK
Company Profile ↓Company Overview
LINK (LINK) is a publicly traded company listed on . The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Recent Developments
- Dec 2025 Revenue of $11.89M (+1.8% YoY); net profit $-1.61M.
- Trailing 12 Months Year-on-year growth — revenue +1.8%.
- 5-Year Trend Long-term compounding — revenue CAGR 1.4%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 1.38% |
| 1 Year: | 1.81% |
Stock Price Performance
| 1 Year: | +2.98% |
| 6 Months: | +48.05% |
| 3 Months: | +55.65% |
| 1 Month: | +12.22% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMAAbove
- RSI (14)52.46 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
- Trading 52.5% below its 52-week high.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2015 | Jun 2015 | Sep 2015 | Mar 2016 | Jun 2016 | Sep 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Sep 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | 2.65M | - | - | 1.92M | 2.16M | 1.69M | 1.70M | 1.55M | 1.57M | 2.06M | 2.22M | 1.99M | 2.04M | 1.85M | 3.28M | 4.05M | 3.08M | 3.12M | 2.90M | 2.67M | 2.66M | 3.41M | 2.96M | 3.07M |
| Gross Profit | 1.14M | 1.45M | 1.51M | 1.67M | 1.84M | 1.95M | 1.74M | 2.06M | 1.66M | 1.41M | 1.55M | 1.05M | 1.08M | 959.00K | 998.00K | 811.00K | 874.00K | 1.13M | 1.29M | 1.24M | 952.00K | 872.00K | 1.59M | 2.06M | 1.46M | 1.25M | 1.30M | 1.10M | 949.00K | 1.54M | 1.24M | 1.34M |
| Operating Income | 251.00K | 451.00K | 476.00K | 618.00K | 914.00K | 937.00K | 531.00K | 839.00K | 532.00K | 219.00K | 430.00K | 103.00K | 203.00K | -72.00K | 41.00K | -79.00K | -60.00K | 133.00K | 259.00K | 18.00K | -151.00K | -190.00K | -173.00K | 406.00K | -92.00K | -751.00K | -313.00K | -476.00K | -849.00K | 66.00K | -313.00K | -450.00K |
| Net Income | - | - | - | - | 749.00K | 614.00K | 364.00K | 549.00K | 352.00K | 118.00K | 359.00K | 99.00K | 111.00K | -18.00K | 13.00K | 65.00K | -43.00K | 63.00K | 223.00K | 142.00K | 112.00K | 6.00K | -191.00K | 381.00K | -125.00K | -741.00K | -307.00K | -523.00K | -805.00K | 100.00K | -336.00K | -338.00K |
| Diluted EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.00 | - | -0.01 | 0.01 | 0.03 | 0.01 | 0.00 | -0.01 | -0.03 | 0.03 | -0.02 | -0.09 | -0.04 | -0.04 | -0.06 | - | -0.03 | -0.02 |
| R&D Expense | 161.00K | 257.00K | 219.00K | 141.00K | 174.00K | 183.00K | 178.00K | 157.00K | 230.00K | 224.00K | 237.00K | 222.00K | 292.00K | 285.00K | 293.00K | 208.00K | 217.00K | 232.00K | 105.00K | 263.00K | 330.00K | 319.00K | 527.00K | 650.00K | 588.00K | 576.00K | 510.00K | 486.00K | 434.00K | 363.00K | 354.00K | 303.00K |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 10.51M | 11.89M | 11.15M | 7.30M | 6.89M | 7.48M | 7.49M | 13.94M | 11.68M | 11.89M |
| Gross Profit | 5.64M | 7.01M | 6.86M | 3.31M | 3.90M | 4.06M | 3.86M | 6.56M | 4.85M | 4.63M |
| Operating Income | 1.68M | 2.85M | 2.14M | -214.00K | 110.00K | -79.00K | -668.00K | -439.00K | -2.05M | -1.83M |
| Net Income | 1.73M | 2.89M | 1.26M | -457.00K | 113.00K | -734.00K | 1.67M | -383.00K | -1.98M | -1.61M |
| Diluted EPS | - | - | - | -0.07 | 0.02 | -0.12 | 0.13 | -0.08 | -0.16 | -0.13 |
| R&D Expense | 841.00K | 623.00K | 829.00K | 916.00K | 918.00K | 893.00K | 1.22M | 2.33M | 2.05M | 1.50M |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | 7.56M | 10.47M | 11.83M | - | 9.33M | 10.02M | 13.78M | 14.98M | 15.06M | 13.12M | 11.74M |
| Total Equity | 4.86M | 6.66M | 9.60M | 11.13M | 8.98M | 8.57M | 8.84M | 12.71M | 13.85M | 13.03M | 10.49M | 9.22M |
| Cash & Equivalents | 2.38M | 4.43M | 6.01M | 7.77M | - | 5.81M | 6.12M | 10.78M | 10.09M | 4.30M | 2.95M | 2.72M |
| Total Liabilities | - | 899.00K | 873.00K | 703.00K | - | 761.00K | 1.18M | 1.07M | 1.14M | 2.03M | 2.62M | 2.52M |
| Current Liabilities | - | 859.00K | 873.00K | 703.00K | - | 687.00K | 1.04M | 1.04M | 1.09M | 1.38M | 1.39M | 1.66M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | - | 1.89M | 2.05M | 2.00K | 39.00K | 231.00K | -915.00K | -116.00K | -367.00K | -112.00K |
| Investing Cash Flow | - | -230.00K | -429.00K | -233.00K | -90.00K | -159.00K | 735.00K | -4.88M | -491.00K | -56.00K |
| Financing Cash Flow | - | - | 34.00K | -6.00K | 186.00K | 4.52M | -350.00K | -750.00K | -400.00K | -91.00K |
| Capital Expenditure | -68.00K | -191.00K | -394.00K | -141.00K | -7.00K | -159.00K | -42.00K | -123.00K | -177.00K | -56.00K |
| Free Cash Flow | - | 1.70M | 1.65M | -139.00K | 32.00K | 72.00K | -957.00K | -239.00K | -544.00K | -168.00K |
| Share Buybacks | - | - | - | - | - | - | - | 350.00K | - | - |
Ratios (Annual)
Figures in %.
| Metric | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | 53.7% | 58.9% | 61.5% | 45.3% | 56.6% | 54.3% | 51.5% | 47.1% | 41.5% | 38.9% |
| Operating Margin % | 16.0% | 24.0% | 19.2% | -2.9% | 1.6% | -1.1% | -8.9% | -3.1% | -17.6% | -15.4% |
| Net Margin % | 16.5% | 24.3% | 11.3% | -6.3% | 1.6% | -9.8% | 22.3% | -2.7% | -17.0% | -13.6% |
| ROE % | 26.0% | 30.1% | 11.3% | -5.3% | 1.3% | -5.8% | 12.1% | -2.9% | -18.9% | -17.5% |
| ROCE % | 25.1% | 29.7% | 19.2% | -2.5% | 1.2% | -0.6% | -4.8% | -3.2% | -17.5% | -18.2% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for LINK
Chipotle stock falls on potential link to salmonella outbreak in Minnesota - CNBC
<a href="https://news.google.com/rss/articles/CBMikAFBVV95cUxQV0I1cm1VbmFNbDNKNDdERWJpZHlCcW9uMUI2ckM3OFp3VTR5RGRCeW42SG41M0VGdjNiQmR6TlNWMEpqaXJsODF5alZoNW9OUFRUcTU2MGg2ZEN6eFY4RFJ2RmNtSzByZGdab2dlaDg2bXNGOHZpUVVrbm9UTnMzUFV1YmxQX3VPc3ptTl…
Dow, S&P 500 close at record on AI-linked earnings, Mideast deal hopes - Reuters
<a href="https://news.google.com/rss/articles/CBMitAFBVV95cUxOMHk5N1NJZXlfQ196NTA1SjFaUUtUaDd0UXNDY2FsLWM2aE1VTElKc1oxaXFMbmd1M2kwcXVmaFBKbEo3TmFmY2lfRVFraDFVcTZpTTNfbGU2VU9iZnQ0Q2xBR0ZCVHFmRUktbVk0VTR1RVVYNzVxNEVUa3dJbmFQXzQ0SldqNzVoSXAtRn…
South Korea’s president wanted a hot stock market. He got more than he bargained for - Financial Times
<a href="https://news.google.com/rss/articles/CBMihAFBVV95cUxQWEV4OGVCcXBsUG00UzdGVFVGWVFFLUlOeHZrSi1vTFhJdWZmQXhSVVRHWThXY0FEQjcyZXphbFREZmswcHhrZXNyUkR3V0RCRmF4amtkc2dGWENsRERVZGItbzZ6dGhNckZUQ2RBNXlySHlYS1ZWRlMtcUxRYndRamd1V08?oc=5" targ…
BitGo Link Gives Trading Teams One View Across Exchanges - Stock Titan
<a href="https://news.google.com/rss/articles/CBMivgFBVV95cUxNLXZfbVB6RXhGemNhSi1OSHMxZDZHZU9lbkVJYUFON3cxUGI0S1gtb3FfdHh2T2xzU1FYbWNDUkNzZklDOE4xVFQ4N1ltaTJWeC1IbURmbUtJT0pfclpLa1ltbGN4bDNLZUk4ME52bUJsOWlsRmIwalNmZmJsaTdMTjF0YUZpUFU2akRKME…
Chipotle slides on the stock market after a potential link to a salmonella outbreak - marketscreener.com
<a href="https://news.google.com/rss/articles/CBMi0gFBVV95cUxPWlg0OGcxRDA4UTV4ZV9seGZVbWtiMGVoRzBoV1U4X2ptNzZKMTN6U1VEV3N4WDNQVVE2aGpPU3dOdjZzdVNENWNMcGNHSTZCN1ptbGt0bXlkNVE0cEtLT080Snk5Ync5aVZ2aHNNdzlCbEdlcF9YUEFfenpWaVdIZ29fQTRkR2JCZkVWNj…
CME Group (CME) Stock Could Be 4% Overvalued Despite Treasury Link Launch - Yahoo Finance Singapore
<a href="https://news.google.com/rss/articles/CBMif0FVX3lxTE1ZV3ZTM1Z1MXozREpQeEdCY2JOczhWVnpuREYxS2FseEg5b3M5S25IUWFld3VLT3BGbzhWN0tLZjhuUGJaQTJyR3NuNDBUQmZNb3BRdS1sbWFiM3lEOGItSndLaGRMcW15SmFyZEgyYjRFTGFoeDAyWm5YUWZraXc?oc=5" target="_bla…
LINK — Frequently Asked Questions
What is the current share price of LINK?
As of 2026-08-05 17:25 PDT, LINK trades at $4.54 on NASDAQ/NYSE. Its 52-week range is $2.75 to $9.57.
What is the P/E ratio of LINK?
LINK trades at a trailing price-to-earnings (P/E) ratio of -34.92.
What is the return on equity (ROE) of LINK?
LINK has a return on equity (ROE) of -17.51%. Its return on capital employed (ROCE) is -18.15%.
Is LINK a good stock to buy?
This page provides a data-driven analysis of LINK, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.